L

Latigo Biotherapeutics

Clinical-stage biotech developing Nav1.8 inhibitors

Senior Director, Scientific Communications

Biology & BiotechPosted on Nov 17
Full-timeNo salary listed

About the Job

Requirements

  • A PhD, PharmD, MD, or other advanced scientific/healthcare degree is preferred.
  • At least 8 years of pharmaceutical or biotechnology experience, with significant experience in Scientific Communications, Publications, or Medical Affairs.
  • Demonstrated experience developing and executing global publication and scientific communications strategies.
  • A strong track record of developing manuscripts, abstracts, congress presentations, scientific platforms, and medical materials.
  • Experience working with external authors, opinion leaders, publication agencies, and medical writing partners.
  • A strong understanding of publication standards and good publication practices.
  • Scientific writing, communication, project management, and cross-functional leadership skills, with a focus on execution.
  • Ability to operate in a fast-paced, entrepreneurial biotechnology environment.

Responsibilities

  • Lead development and execution of the Scientific Communications strategy, aligned with Medical Affairs, clinical development, and corporate objectives.
  • Develop and maintain the scientific narrative and communication platform across the company’s pain portfolio.
  • Lead publication planning and execution, including manuscripts, abstracts, posters, and oral presentations.
  • Develop and execute the scientific congress strategy, including prioritization and sequencing of data across key congresses.
  • Partner across matrix teams to identify and prioritize publication opportunities, evidence gaps, and data dissemination needs.
  • Lead development of scientific materials, including scientific platforms, core medical decks, FAQs, field medical resources, dossiers, and other medical content.
  • Ensure scientific communications are accurate, consistent, balanced, and compliant with applicable standards and requirements.
  • Partner with internal and external authors, investigators, and opinion leaders to support high-quality and timely scientific publications.
  • Manage external medical writing, publication, and scientific communications agencies, including timelines, budgets, and deliverables.
  • Support pre-launch and launch readiness through development of scientific communications, training resources, and foundational medical content.
  • Provide scientific communications leadership across cross-functional teams and help build Medical Affairs capabilities as the company grows.

Desired Qualifications

  • Experience supporting late-stage development, pre-launch, and/or launch.
  • Scientific expertise in pain, neuroscience, or a related therapeutic area.

About the Company

Latigo Biotherapeutics

Clinical-stage biotech developing Nav1.8 inhibitors

Latigo Biotherapeutics develops non-opioid pain medicines by discovering and advancing small-molecule drugs, focusing on Nav1.8 channels in peripheral sensory neurons. By blocking Nav1.8, their therapies aim to stop pain at its source, reducing opioid-related risks like addiction and dizziness. The company uses a genetics-informed discovery engine with AI, machine learning, and structure-based design; LTG-001 targets acute pain and LTG-305 targets chronic pain, both in clinical stages. Its differentiated approach centers on genetically validated pain pathways, strong funding, and experienced leadership, with the goal of delivering safe, effective non-opioid analgesics that address pain at its source.

Company size
51-200
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Latigo Biotherapeutics

See more jobs